Device Trial Radar · NCT03247829
Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™
Last checked: Nov 20, 2026Latest source record: Apr 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
101
Actual
Start
Aug 24, 2017
Primary completion
Mar 6, 2020
Study completion Jun 30, 2020
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Aug 14, 2017
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This observational post market study is intended to characterize hemodynamic-guided management of patients with an existing left ventricular assist device (LVAD) to protocol specified target ranges and its impact on functional status, quality of life, and readmissions
Conditions
- Heart Failure
Interventions
Hemodynamic management using CardioMEMS HF SystemDevice
Using the CardioMEMS HF System, clinicians will treat to target PA pressure ranges
Primary outcomes
What the sponsor says the trial is designed to measure.
- Six Minute Hall Walk (6MHW) DistanceTime frame: Six Months
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Scripps Health
La Jolla, California
USC University Hospital
Los Angeles, California
Ronald Reagan UCLA Medical Center
Los Angeles, California
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.